TNF Pharmaceuticals Inc. (TNFA) Company Sales Revenue

Corporate emblem and logo of TNF Pharma (TNFA)

Total sales for TNF Pharmaceuticals (TNFA) reflect asset dynamics where the parameter has stabilized at 0.00. The current TNFA model relies on urological developments characterized by high risk volatility. The brand's scientific authority is based on the creation of small-molecule agents against fibrosis. However, fierce competition with industry behemoths and the risk of clinical data shortages create significant barriers to drug approval.

TNFA: TNF Pharmaceuticals, Inc. Company Revenue 07/25/2024 - 09/25/2025

Analytical breakdowns for tnfpharma.com (TNFA)

- market price and analyst price targets:
Comprehensive company analysis:TNF Pharmaceuticals, Inc. (TNFA)
Manufactured products of TNF Pharmaceuticals

A market audit of TNF Pharmaceuticals (TNFA) requires an assessment of the current asset commercialization efficiency during the transformation of its R&D strategy focused on age-related pathologies. This sales time series for TNF Pharmaceuticals captures daily revenue inflows from product sales, allowing investors to determine the business's actual resilience and its level of dependence on new developments through cash flow dynamics.

Key competitors

HLN: Company Sales Revenue|Company Revenue Kenvue (KVUE)|VRNA (Verona Pharma Corp) - Company Sales Revenue|Company Revenue Jyong Biotech MENS|Ligand Pharma - Company Revenue|AMRX - Company Revenue|Company Total Revenue perrigo.com|ALVO (Alvotech SA) - Company Sales|Company Total Sales Volume Liquidia Technologies LQDA|GLPG (Galapagos N.V.) - Revenue and Sales Volume|ANIP: Company Sales Revenue|Company Revenue Afrezza (MNKD)|Revenue and Sales Volume amphastar.com (AMPH)|Revenue and Sales Volume PCRX (pacira.com)|Company Sales Revenue SPRY|Theravance Biopharma Inc - Revenue and Sales Volume|Company Gross Revenue Aquestive Therapeutics AQST|SCPH: Revenue and Sales Volume|Company Sales Tectonic Therapeutic, Inc.|TNXP (tonixpharma.com) - Revenue and Sales Volume|SXTC (China SXT Pharmaceuticals, Inc.) - Company Total Sales|Company Revenue eupraxiapharma.com (EPRX)|Company Total Sales BHST|Company Revenue eXoZymes EXOZ|Company Sales Revenue ORMP|ENTX - Company Revenue|HYFT: Company Revenue|ABVC BioPharma, Inc (ABVC) - Company Revenue|Cumberland Pharma - Company Sales Revenue|QNTM (Quantum BioPharma Corp) - Revenue and Sales Volume|FibroGen, Inc. - Company Annual Revenue|Revenue and Sales Volume TELO|Company Gross Revenue Rani Therapeutics Holdings, Inc.|Company Revenue Synergy CHC Corp. SNYR|Revenue and Sales Volume rallybio.com RLYB|Lexaria Bioscience Corp. - Revenue and Sales Volume|PULM: Company Revenue|PTHL (ftzy.com.cn) - Company Sales|APM: Company Total Sales|LYRA (Lyra Therapeutics Inc) - Revenue and Sales Volume|Company Sales Volume IBO (Impact BioMedical)|Revenue and Sales Volume YCBD|PRFX: Company Annual Revenue|Company Revenue altamiratherapeutics.com CYTO|Revenue and Sales Volume Lipella Pharmaceuticals Inc LIPO|OPTN - Company Revenue|Company Gross Revenue Pieris Pharma PIRS|Procaps Group SA (PROC) - Company Revenue|Company Annual Revenue PTPI (Petros Pharmaceuticals, Inc.)|QLI (Qilian International Holding) - Revenue and Sales Volume|SLRN: Company Sales Revenue|Revenue and Sales Volume TFFP